DTEC vs. SBIO
DTEC (ALPS Disruptive Technologies ETF) and SBIO (ALPS Medical Breakthroughs ETF) are both exchange-traded funds - DTEC is a Technology Equities fund tracking the Indxx Disruptive Technologies Index, while SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index. Both are passively managed. Over the past 5 years, DTEC returned 1.96%/yr vs 3.16%/yr for SBIO. A 0.61 correlation means they provide meaningful diversification when combined. Both charge a 0.50% expense ratio.
Performance
DTEC vs. SBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DTEC achieves a 3.56% return, which is significantly higher than SBIO's 1.95% return.
DTEC
- 1D
- 0.51%
- 1M
- 7.83%
- YTD
- 3.56%
- 6M
- 1.31%
- 1Y
- 5.02%
- 3Y*
- 9.82%
- 5Y*
- 1.96%
- 10Y*
- —
SBIO
- 1D
- 2.35%
- 1M
- -5.55%
- YTD
- 1.95%
- 6M
- 4.13%
- 1Y
- 68.86%
- 3Y*
- 18.38%
- 5Y*
- 3.16%
- 10Y*
- 8.03%
DTEC vs. SBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
DTEC ALPS Disruptive Technologies ETF | 3.56% | 7.21% | 9.89% | 25.03% | -31.29% | 4.89% | 44.12% | 35.44% | -4.96% |
SBIO ALPS Medical Breakthroughs ETF | 1.95% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% |
Correlation
The correlation between DTEC and SBIO is 0.40, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.40 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.52 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.58 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2018 | 0.61 |
Over the past year, the correlation between DTEC and SBIO has dropped to 0.40 - well below their long-term average of 0.61, suggesting their price drivers have been diverging.
DTEC vs. SBIO - Sectors Allocation Comparison
Sectors
DTEC
SBIO
Technology
-
Industrials
-
Healthcare
Financial Services
Energy
-
Utilities
-
Communication Services
-
Real Estate
-
Consumer Cyclical
-
Basic Materials
-
-
Consumer Defensive
-
-
Technology
DTEC
SBIO
-
Industrials
DTEC
SBIO
-
Healthcare
DTEC
SBIO
Financial Services
DTEC
SBIO
Energy
DTEC
SBIO
-
Utilities
DTEC
SBIO
-
Communication Services
DTEC
SBIO
-
Real Estate
DTEC
SBIO
-
Consumer Cyclical
DTEC
SBIO
-
Basic Materials
DTEC
-
SBIO
-
Consumer Defensive
DTEC
-
SBIO
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DTEC vs. SBIO — Risk / Return Rank
DTEC
SBIO
DTEC vs. SBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Disruptive Technologies ETF (DTEC) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| DTEC | SBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.08 | ||
| Sortino ratioReturn per unit of downside risk | -2.72 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.38 | -0.32 |
| Calmar ratioReturn relative to maximum drawdown | 0.25 | 5.47 | -5.22 |
| Martin ratioReturn relative to average drawdown | 0.58 | 16.23 | -15.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| DTEC | SBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.28 | 2.35 | -2.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.09 | 0.09 | -0.01 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.24 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.39 | 0.22 | +0.17 |
Drawdowns
DTEC vs. SBIO - Drawdown Comparison
The maximum DTEC drawdown since its inception was -42.00%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for DTEC and SBIO.
Loading charts...
Drawdown Indicators
| DTEC | SBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.00% | -63.06% | +21.06% |
Max Drawdown (1Y)Largest decline over 1 year | -20.31% | -12.66% | -7.65% |
Max Drawdown (3Y)Largest decline over 3 years | -21.47% | -42.44% | +20.97% |
Max Drawdown (5Y)Largest decline over 5 years | -42.00% | -53.10% | +11.10% |
Max Drawdown (10Y)Largest decline over 10 years | — | -63.06% | — |
Current DrawdownCurrent decline from peak | -4.61% | -14.84% | +10.23% |
Average DrawdownAverage peak-to-trough decline | -13.31% | -28.44% | +15.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.71% | 4.26% | +4.45% |
Volatility
DTEC vs. SBIO - Volatility Comparison
The current volatility for ALPS Disruptive Technologies ETF (DTEC) is 6.58%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 9.85%. This indicates that DTEC experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DTEC | SBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.58% | 9.85% | -3.27% |
Volatility (6M)Calculated over the trailing 6-month period | 14.31% | 22.76% | -8.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.31% | 29.40% | -11.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.07% | 33.57% | -11.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.88% | 33.18% | -10.30% |
DTEC vs. SBIO - Expense Ratio Comparison
Both DTEC and SBIO have an expense ratio of 0.50%.
Dividends
DTEC vs. SBIO - Dividend Comparison
DTEC's dividend yield for the trailing twelve months is around 0.04%, while SBIO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
DTEC ALPS Disruptive Technologies ETF | 0.04% | 0.04% | 0.45% | 0.27% | 0.02% | 0.26% | 0.37% | 0.43% | 0.33% | 0.00% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
Frequently Asked Questions
DTEC and SBIO have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBIO has higher volatility (9.85%) compared to DTEC (6.58%). In terms of maximum drawdown, DTEC dropped -42.00% vs SBIO's -63.06%.
On 5-year performance, SBIO leads with 3.16% vs 1.96% for DTEC. Both ETFs have the same 0.50% expense ratio. On volatility, DTEC has been the lower-risk option at 6.58%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, SBIO has performed better with a 3.16% return vs 1.96%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
DTEC and SBIO have the same expense ratio: 0.50% per year.
DTEC has the higher dividend yield at 0.04%, compared with 0.00% for SBIO.
DTEC is categorized as Technology Equities, while SBIO is Health & Biotech Equities. DTEC tracks Indxx Disruptive Technologies Index, while SBIO tracks S-Network Medical Breakthroughs Index.
SBIO currently has the higher Sharpe Ratio (2.35 vs 0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DTEC and SBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer